The industry might consider coordinating an effort to prevent advisory committees from using outcomes as tools to present one-sided versions of price negotiations.
If this does signal a new way of communicating, the industry has tools to deploy
July 9, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Firebrick Pharma targets breakout year in 2026 as Nasodine expansion accelerates
March 4, 2026 - - Australian Biotech -
AdAlta strengthens clinical push for breakthrough solid cancer therapy
March 4, 2026 - - Australian Biotech -
Island Pharmaceuticals deepens US biodefence ties to advance Marburg treatment
March 4, 2026 - -
PYC Therapeutics secures strong backing as retail offer adds $47 million to capital raise
March 4, 2026 - - Australian Biotech -
Alterity strengthens clinical leadership with appointment of neurologist Daniel Claassen
March 4, 2026 - - Australian Biotech -
Australian medtech innovators move closer to procurement through national capability program
March 4, 2026 - - Australian Biotech -
New report says faster and fairer access to medicines within reach for New Zealand
March 3, 2026 - - Latest News

